BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/10/2022 5:40:20 AM | Browse: 352 | Download: 589
 |
Received |
|
2022-02-16 17:36 |
|
Peer-Review Started |
|
2022-02-16 17:39 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-03-09 01:17 |
|
Revised |
|
2022-03-22 14:38 |
|
Second Decision |
|
2022-04-15 02:03 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-04-15 21:03 |
|
Articles in Press |
|
2022-04-15 21:03 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-04-27 17:00 |
|
Typeset the Manuscript |
|
2022-05-30 07:10 |
|
Publish the Manuscript Online |
|
2022-06-10 05:40 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Review |
| Article Title |
Hepatocellular carcinoma, hepatitis C virus infection and miRNA involvement: Perspectives for new therapeutic approaches
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ester Badami, Rosalia Busà, Bruno Douradinha, Giovanna Russelli, Vitale Miceli, Alessia Gallo, Giovanni Zito, Pier Giulio Conaldi and Gioacchin Iannolo |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Gioacchin Iannolo, BSc, PhD, Research Scientist, Department of Research, Mediterranean Institute for Transplantation and Advanced Specialized Therapies (IRCCS-ISMETT), Via E. Tricomi 5, Palermo 90127, Italy. giannolo@ismett.edu |
| Key Words |
Hepatocellular carcinoma; miRNA; Liver; Hepatitis C virus; miRNAs; Direct-acting antivirals; Extracellular vesicles; Transplantation |
| Core Tip |
Hepatocellular carcinoma (HCC) is one of the most life-threatening cancers in the world. Among other factors, HCC is frequently caused by chronic hepatitis C virus infection. Currently, the mechanisms responsible for its neoplastic transformation are not completely understood. Regardless of the recent discovery and therapeutic use of latest-generation direct-acting antivirals, HCC remains an unsolved problem, even after viral eradication. In this scenario, miRNAs can become both a diagnostic tool and, hopefully, a novel therapeutic approach. |
| Publish Date |
2022-06-10 05:40 |
| Citation |
Badami E, Busà R, Douradinha B, Russelli G, Miceli V, Gallo A, Zito G, Conaldi PG, Iannolo G. Hepatocellular carcinoma, hepatitis C virus infection and miRNA involvement: Perspectives for new therapeutic approaches. World J Gastroenterol 2022; 28(22): 2417-2428 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i22/2417.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i22.2417 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
